NUR 600 Exam 1: Advanced Clinical Pharmacology
- St. Thomas University Updated and Latest
Questions and Correct Answers with Rationale
1. Which pharmacokinetic process is primarily affected when a patient has significant liver
cirrhosis?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: C
Rationale: The liver is the primary organ responsible for the metabolic transformation of
drugs. Liver cirrhosis reduces the enzymatic capacity of hepatocytes to process
medications effectively. This can lead to decreased drug clearance and increased risk of
toxicity in the patient. Clinicians must adjust dosages or choose alternative drugs to
prevent adverse effects. Understanding metabolism is essential for safe prescribing in
patients with hepatic impairment.
2. What is the primary characteristic of a drug that acts as a full agonist at a receptor site?
A. It binds to the receptor and produces the maximal possible response.
B. It binds to the receptor but produces no biological response.
C. It blocks other ligands from binding to the receptor.
D. It requires a higher concentration to achieve the same effect as a partial agonist.
Correct Answer: A
Rationale: A full agonist possesses high intrinsic activity and can elicit the maximal
response of the receptor system. Unlike antagonists, agonists facilitate a biological change
once they are bound to the target. The effectiveness of the drug is determined by its ability
to stimulate the receptor to its full capacity. This concept is fundamental in
pharmacodynamics to understand how drugs exert their therapeutic effects. Clinicians use
this knowledge to predict the magnitude of a drug’s pharmacological action.
3. Which term describes the percentage of an administered drug dose that reaches the
systemic circulation in an unchanged form?
A. Clearance
B. Volume of distribution
C. Bioavailability
,D. Half-life
Correct Answer: C
Rationale: Bioavailability is a crucial measure used to compare different drug formulations
and routes of administration. For intravenous drugs, the bioavailability is considered 100%
because the entire dose enters the bloodstream directly. Oral medications often have lower
bioavailability due to incomplete absorption and the first-pass effect in the liver. Factors
such as food intake and gastrointestinal motility can also influence this percentage.
Assessing bioavailability helps providers determine the appropriate dosage for various
administration routes.
4. If a drug has a half-life of 6 hours, how many hours will it take for approximately 94% of
the drug to be eliminated from the body?
A. 24 hours
B. 12 hours
C. 6 hours
D. 48 hours
Correct Answer: A
Rationale: The rule of thumb states that it takes about four to five half-lives for a drug to
be eliminated. After one half-life, 50% remains; after two, 25%; after three, 12.5%; and
after four, 6.25% remains. Therefore, after 24 hours (four half-lives of 6 hours each),
approximately 93.75% of the drug is cleared. This calculation is vital for determining the
duration of drug action and potential for toxicity. It also guides the clinician on when it is
safe to start a different medication.
5. Which of the following describes the first-pass effect?
A. The initial binding of a drug to plasma proteins.
B. The first time a drug crosses the blood-brain barrier.
C. The rapid metabolism of a drug in the liver before it reaches systemic circulation.
D. The primary excretion of a drug through the kidneys.
Correct Answer: C
Rationale: The first-pass effect is a phenomenon of drug metabolism whereby the
concentration of a drug is greatly reduced before it reaches the systemic circulation. This
occurs primarily with oral medications because they are absorbed by the digestive system
and enter the portal vein. The liver then metabolizes the drug, which can render some of it
inactive. Drugs with a high first-pass effect often require higher oral doses than parenteral
doses. Understanding this concept is essential for selecting the most effective route of
administration.
, 6. A patient is taking a drug that is known to be a potent CYP450 enzyme inducer. What is the
most likely effect on a second drug metabolized by the same enzyme?
A. The serum levels of the second drug will decrease.
B. The serum levels of the second drug will increase.
C. The second drug will become more toxic.
D. There will be no change in the second drug’s effect.
Correct Answer: A
Rationale: Enzyme induction involves increasing the synthesis or activity of metabolic
enzymes like the CYP450 system. When these enzymes are induced, they process the
substrate drug more rapidly than usual. As a result, the plasma concentration of the second
drug falls, potentially leading to therapeutic failure. Clinicians must be vigilant when
adding or removing medications that are known inducers. Dose adjustments are frequently
necessary to maintain therapeutic levels of the affected drug.
7. According to the Controlled Substances Act, which schedule includes drugs with a high
potential for abuse but have a currently accepted medical use?
A. Schedule II
B. Schedule I
C. Schedule IV
D. Schedule V
Correct Answer: A
Rationale: Schedule II drugs are classified as having a high potential for abuse that may
lead to severe psychological or physical dependence. Unlike Schedule I drugs, they have an
accepted medical use in the United States. Examples include morphine, oxycodone, and
methylphenidate. Prescribing these substances requires strict adherence to legal
regulations, such as no refills and specific documentation. NP students must master these
regulations to ensure safe and legal prescribing practices.
8. Which factor most significantly affects the distribution of a highly lipophilic drug?
A. The patient’s total body water.
B. The glomerular filtration rate.
C. The patient’s body fat percentage.
D. The gastric pH.
Correct Answer: C
- St. Thomas University Updated and Latest
Questions and Correct Answers with Rationale
1. Which pharmacokinetic process is primarily affected when a patient has significant liver
cirrhosis?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: C
Rationale: The liver is the primary organ responsible for the metabolic transformation of
drugs. Liver cirrhosis reduces the enzymatic capacity of hepatocytes to process
medications effectively. This can lead to decreased drug clearance and increased risk of
toxicity in the patient. Clinicians must adjust dosages or choose alternative drugs to
prevent adverse effects. Understanding metabolism is essential for safe prescribing in
patients with hepatic impairment.
2. What is the primary characteristic of a drug that acts as a full agonist at a receptor site?
A. It binds to the receptor and produces the maximal possible response.
B. It binds to the receptor but produces no biological response.
C. It blocks other ligands from binding to the receptor.
D. It requires a higher concentration to achieve the same effect as a partial agonist.
Correct Answer: A
Rationale: A full agonist possesses high intrinsic activity and can elicit the maximal
response of the receptor system. Unlike antagonists, agonists facilitate a biological change
once they are bound to the target. The effectiveness of the drug is determined by its ability
to stimulate the receptor to its full capacity. This concept is fundamental in
pharmacodynamics to understand how drugs exert their therapeutic effects. Clinicians use
this knowledge to predict the magnitude of a drug’s pharmacological action.
3. Which term describes the percentage of an administered drug dose that reaches the
systemic circulation in an unchanged form?
A. Clearance
B. Volume of distribution
C. Bioavailability
,D. Half-life
Correct Answer: C
Rationale: Bioavailability is a crucial measure used to compare different drug formulations
and routes of administration. For intravenous drugs, the bioavailability is considered 100%
because the entire dose enters the bloodstream directly. Oral medications often have lower
bioavailability due to incomplete absorption and the first-pass effect in the liver. Factors
such as food intake and gastrointestinal motility can also influence this percentage.
Assessing bioavailability helps providers determine the appropriate dosage for various
administration routes.
4. If a drug has a half-life of 6 hours, how many hours will it take for approximately 94% of
the drug to be eliminated from the body?
A. 24 hours
B. 12 hours
C. 6 hours
D. 48 hours
Correct Answer: A
Rationale: The rule of thumb states that it takes about four to five half-lives for a drug to
be eliminated. After one half-life, 50% remains; after two, 25%; after three, 12.5%; and
after four, 6.25% remains. Therefore, after 24 hours (four half-lives of 6 hours each),
approximately 93.75% of the drug is cleared. This calculation is vital for determining the
duration of drug action and potential for toxicity. It also guides the clinician on when it is
safe to start a different medication.
5. Which of the following describes the first-pass effect?
A. The initial binding of a drug to plasma proteins.
B. The first time a drug crosses the blood-brain barrier.
C. The rapid metabolism of a drug in the liver before it reaches systemic circulation.
D. The primary excretion of a drug through the kidneys.
Correct Answer: C
Rationale: The first-pass effect is a phenomenon of drug metabolism whereby the
concentration of a drug is greatly reduced before it reaches the systemic circulation. This
occurs primarily with oral medications because they are absorbed by the digestive system
and enter the portal vein. The liver then metabolizes the drug, which can render some of it
inactive. Drugs with a high first-pass effect often require higher oral doses than parenteral
doses. Understanding this concept is essential for selecting the most effective route of
administration.
, 6. A patient is taking a drug that is known to be a potent CYP450 enzyme inducer. What is the
most likely effect on a second drug metabolized by the same enzyme?
A. The serum levels of the second drug will decrease.
B. The serum levels of the second drug will increase.
C. The second drug will become more toxic.
D. There will be no change in the second drug’s effect.
Correct Answer: A
Rationale: Enzyme induction involves increasing the synthesis or activity of metabolic
enzymes like the CYP450 system. When these enzymes are induced, they process the
substrate drug more rapidly than usual. As a result, the plasma concentration of the second
drug falls, potentially leading to therapeutic failure. Clinicians must be vigilant when
adding or removing medications that are known inducers. Dose adjustments are frequently
necessary to maintain therapeutic levels of the affected drug.
7. According to the Controlled Substances Act, which schedule includes drugs with a high
potential for abuse but have a currently accepted medical use?
A. Schedule II
B. Schedule I
C. Schedule IV
D. Schedule V
Correct Answer: A
Rationale: Schedule II drugs are classified as having a high potential for abuse that may
lead to severe psychological or physical dependence. Unlike Schedule I drugs, they have an
accepted medical use in the United States. Examples include morphine, oxycodone, and
methylphenidate. Prescribing these substances requires strict adherence to legal
regulations, such as no refills and specific documentation. NP students must master these
regulations to ensure safe and legal prescribing practices.
8. Which factor most significantly affects the distribution of a highly lipophilic drug?
A. The patient’s total body water.
B. The glomerular filtration rate.
C. The patient’s body fat percentage.
D. The gastric pH.
Correct Answer: C
